You are here: Industry Insights > Pfizer

News List

Pfizer to allow generic COVID pill in 95 countries ExpressPharma
November 18, 2021
Pfizer and the UN-backed Medicines Patent Pool announced a voluntary licence yesterday on Pfizer’s generic version of COVID pill. As the pandemic continues, and in light of the ongoing inequity in global vaccine access...
Israel to procure courses of Pfizer’s Covid-19 antiviral pill Pharmaceutical-Technology
November 16, 2021
The Israeli Government has entered an agreement to procure tens of thousands of courses of Pfizer’s investigational Covid-19 antiviral drug.
Pfizer Asks FDA to Approve Booster Shots for All U.S. Adults Drugs
November 11, 2021
As concerns mount that holiday travel and indoor gatherings will foster the spread of COVID-19, Pfizer on Tuesday asked the U.S. Food and Drug Administration to approve booster shots...
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot Drugs
November 11, 2021
About 900,000 U.S. children aged 5 to 11 years received their initial dose of the Pfizer COVID-19 vaccine during the first week of eligibility for that age group, the Biden administration said Wednesday.
Oral antiviral candidate Paxlovid™ reduces COVID-19 risks by 89 percent EuropeanPharmaceuticalReview
November 09, 2021
Pfizer has announced its investigational novel COVID-19 oral antiviral candidate, Paxlovid™, significantly reduced hospitalisation and death, based on an interim analysis of the Phase II/III EPIC-HR randomised...
Pfizer raises COVID vaccine sales forecast to $36 billion for 2021 ExpressPharma
November 08, 2021
Pfizer recently raised the full-year sales forecast for its COVID-19 vaccine by 7.5 per cent to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.
Pfizer Says New COVID-19 Pill Cuts Severe Disease by 89 Percent Drugs
November 08, 2021
Pfizer Inc. announced Friday that its experimental COVID-19 pill slashed the risk of hospitalization and death by 89 percent in infected high-risk people.
Pfizer, BioNTech to supply Covid-19 vaccine paediatric doses to US By PBR Staff Writer Pharmaceutical-Business-Review
November 03, 2021
Pfizer and its partner BioNTech have announced that the US government has purchased additional paediatric doses of their Covid-19 vaccine, as it prepares for paediatric vaccinations.
Pfizer and BioNTech Receive First FDA EUA for COVID-19 Vaccine in Children AmericanPharmaceuticalReview
November 02, 2021
Pfizer and BioNTech announced that the FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to <12 years).
Trillium Therapeutics Receives Final Court Order Approving Arrangement FirstWordPharma
October 29, 2021
Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce that...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page